Table 3.
Expenditure on ocular topical anti-infectives dispensed from 2013 to 2019 1.
| Drug | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|
| Levofloxacin | 2,342,514(52.0) | 2,453,344(54.2) | 2,875,647(60.4) | 3,372,923(62.2) | 4,094,023(65.5) | 3,575,850(65.2) | 3,931,192(67.1) |
| Ofloxacin | 749,390(16.6) | 714,976(15.8) | 640,714(13.5) | 636,032(11.7) | 544,397(8.70) | 437,614(7.97) | 419,011(7.15) |
| Tobramycin/dexamethasone | 581,239(12.9) | 587,307(13.0) | 616,420(13.0) | 749,588(13.8) | 818,469(13.1) | 804,675(14.7) | 845,147(14.4) |
| Tobramycin | 352,569(7.83) | 352,601(7.79) | 249,359(5.24) | 248,459(4.58) | 277,593(4.44) | 235,096(4.28) | 236,677(4.04) |
| Ganciclovir | 215,112(4.78) | 200,949(4.44) | 208,749(4.39) | 226,533(4.18) | 230,249(3.68) | 191,290(3.49) | 182,981(3.12) |
| Other | 262,887(5.84) | 219,362(4.84) | 168,587(3.54) | 189,612(3.50) | 290,198(4.64) | 243,031(4.43) | 245,938(4.20) |
1 Data are represented as cost in Chinese Yuan (percentage %).